These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 26553164)

  • 21. Combination Therapy with Zonisamide and Antiparkinson Drugs for Parkinson's Disease: A Meta-Analysis.
    Matsunaga S; Kishi T; Iwata N
    J Alzheimers Dis; 2017; 56(4):1229-1239. PubMed ID: 28157097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Effects of Coenzyme Q10 Supplementation on Blood Pressures Among Patients with Metabolic Diseases: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Tabrizi R; Akbari M; Sharifi N; Lankarani KB; Moosazadeh M; Kolahdooz F; Taghizadeh M; Asemi Z
    High Blood Press Cardiovasc Prev; 2018 Mar; 25(1):41-50. PubMed ID: 29330704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Effects of Coenzyme Q10 Supplementation on Lipid Profiles Among Patients with Metabolic Diseases: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Sharifi N; Tabrizi R; Moosazadeh M; Mirhosseini N; Lankarani KB; Akbari M; Chamani M; Kolahdooz F; Asemi Z
    Curr Pharm Des; 2018; 24(23):2729-2742. PubMed ID: 29623830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coenzyme Q10 supplementation and oxidative stress parameters: a systematic review and meta-analysis of clinical trials.
    Akbari A; Mobini GR; Agah S; Morvaridzadeh M; Omidi A; Potter E; Fazelian S; Ardehali SH; Daneshzad E; Dehghani S
    Eur J Clin Pharmacol; 2020 Nov; 76(11):1483-1499. PubMed ID: 32583356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rasagiline as Adjunct to Levodopa for Treatment of Parkinson's Disease: A Systematic Review and Meta-Analysis.
    Kano O; Tsuda H; Hayashi A; Arai M
    Parkinsons Dis; 2022; 2022():4216452. PubMed ID: 36081594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antioxidants, supplements, and Parkinson's disease.
    Weber CA; Ernst ME
    Ann Pharmacother; 2006 May; 40(5):935-8. PubMed ID: 16622156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum levels of coenzyme Q10 in patients with Parkinson's disease.
    Jiménez-Jiménez FJ; Molina JA; de Bustos F; García-Redondo A; Gómez-Escalonilla C; Martínez-Salio A; Berbel A; Camacho A; Zurdo M; Barcenilla B; Enríquez de Salamanca R; Arenas J
    J Neural Transm (Vienna); 2000; 107(2):177-81. PubMed ID: 10847558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of statin treatment on circulating coenzyme Q10 concentrations: an updated meta-analysis of randomized controlled trials.
    Qu H; Meng YY; Chai H; Liang F; Zhang JY; Gao ZY; Shi DZ
    Eur J Med Res; 2018 Nov; 23(1):57. PubMed ID: 30414615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of coenzyme Q10 supplementation on metabolic profile in diabetes: a systematic review and meta-analysis.
    Suksomboon N; Poolsup N; Juanak N
    J Clin Pharm Ther; 2015 Aug; 40(4):413-8. PubMed ID: 25913756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroprotection of Coenzyme Q10 in Neurodegenerative Diseases.
    Yang X; Zhang Y; Xu H; Luo X; Yu J; Liu J; Chang RC
    Curr Top Med Chem; 2016; 16(8):858-66. PubMed ID: 26311425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meta-analysis of randomized controlled trials of the effects of probiotics in Parkinson's disease.
    Chu C; Yu L; Li Y; Guo H; Zhai Q; Chen W; Tian F
    Food Funct; 2023 Apr; 14(8):3406-3422. PubMed ID: 36974511
    [No Abstract]   [Full Text] [Related]  

  • 32. A possible role of coenzyme Q10 in the etiology and treatment of Parkinson's disease.
    Shults CW; Haas RH; Beal MF
    Biofactors; 1999; 9(2-4):267-72. PubMed ID: 10416040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coenzyme Q10: a review of its promise as a neuroprotectant.
    Young AJ; Johnson S; Steffens DC; Doraiswamy PM
    CNS Spectr; 2007 Jan; 12(1):62-8. PubMed ID: 17192765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effectiveness of creatine treatment for Parkinson's disease: an updated meta-analysis of randomized controlled trials.
    Mo JJ; Liu LY; Peng WB; Rao J; Liu Z; Cui LL
    BMC Neurol; 2017 Jun; 17(1):105. PubMed ID: 28577542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of probiotic supplements on Parkinson's disease: A systematic review and meta-analysis.
    Jin X; Dong W; Chang K; Yan Y; Liu X
    Complement Ther Med; 2024 Jun; 82():103045. PubMed ID: 38705493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prophylactic treatment with coenzyme Q10 in patients undergoing cardiac surgery: could an antioxidant reduce complications? A systematic review and meta-analysis.
    de Frutos F; Gea A; Hernandez-Estefania R; Rabago G
    Interact Cardiovasc Thorac Surg; 2015 Feb; 20(2):254-9. PubMed ID: 25344142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Coenzyme Q10 in Parkinson's disease. Symptomatic or neuroprotective effects?].
    Storch A
    Nervenarzt; 2007 Dec; 78(12):1378-82. PubMed ID: 17508194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acupuncture for the Treatment of Neuropsychiatric Symptoms in Parkinson's Disease: A Systematic Review and Meta-Analysis.
    Zhang A; Song Z; Di A; Zhou Z; Zheng L; Zhuang L
    Complement Ther Med; 2024 Mar; 80():103020. PubMed ID: 38185400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of coenzyme Q10 supplementation on biomarkers of exercise-induced muscle damage, physical performance, and oxidative stress: A GRADE-assessed systematic review and dose-response meta-analysis of randomized controlled trials.
    Talebi S; Pourgharib Shahi MH; Zeraattalab-Motlagh S; Asoudeh F; Ranjbar M; Hemmati A; Talebi A; Wong A; Mohammadi H
    Clin Nutr ESPEN; 2024 Apr; 60():122-134. PubMed ID: 38479900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes.
    Rascol O; Fitzer-Attas CJ; Hauser R; Jankovic J; Lang A; Langston JW; Melamed E; Poewe W; Stocchi F; Tolosa E; Eyal E; Weiss YM; Olanow CW
    Lancet Neurol; 2011 May; 10(5):415-23. PubMed ID: 21482191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.